GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NDatalyze Corp (OTCPK:NDATF) » Definitions » Cash, Cash Equivalents, Marketable Securities

NDatalyze (NDatalyze) Cash, Cash Equivalents, Marketable Securities : $0.67 Mil (As of Nov. 2023)


View and export this data going back to 2021. Start your Free Trial

What is NDatalyze Cash, Cash Equivalents, Marketable Securities?

NDatalyze's quarterly cash, cash equivalents, marketable securities declined from May. 2023 ($0.50 Mil) to Aug. 2023 ($0.46 Mil) but then increased from Aug. 2023 ($0.46 Mil) to Nov. 2023 ($0.67 Mil).

NDatalyze's annual cash, cash equivalents, marketable securities increased from Feb. 2021 ($0.62 Mil) to Feb. 2022 ($1.26 Mil) but then declined from Feb. 2022 ($1.26 Mil) to Feb. 2023 ($0.55 Mil).


NDatalyze Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for NDatalyze's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NDatalyze Cash, Cash Equivalents, Marketable Securities Chart

NDatalyze Annual Data
Trend Feb19 Feb20 Feb21 Feb22 Feb23
Cash, Cash Equivalents, Marketable Securities
0.11 0.45 0.62 1.26 0.55

NDatalyze Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.55 0.50 0.46 0.67

NDatalyze Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


NDatalyze  (OTCPK:NDATF) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


NDatalyze Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of NDatalyze's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


NDatalyze (NDatalyze) Business Description

Industry
Traded in Other Exchanges
Address
707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.

NDatalyze (NDatalyze) Headlines

From GuruFocus